Tuberculin purified protein derivative (Mantoux, Sanofi)

结核菌素纯蛋白衍生物(赛诺菲)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTuberculin purified protein derivative (Mantoux, Sanofi)
Drug Alias Name结核菌素纯蛋白衍生物结核菌素纯蛋白衍化物Tubersolprotein derivative
ClassificationBiologicsDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDiagnostic agentsTuberculosis, Pulmonary
Global Approved IndicationsDiagnostic agentsTuberculosis, Pulmonary
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1969/09/26
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsDiagnostic agentsTuberculosis, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeV04CF01
Related LinksDrugBank